Literature DB >> 22908836

A blinded trial to investigate whether 'pressure-familiar' individuals can determine chamber pressure.

Lindell K Weaver1, Susan K Churchill, James Bell, Kayla Deru, Gregory L Snow.   

Abstract

INTRODUCTION: We conducted a prospective study to determine whether divers or hyperbaric chamber attendants could discern chamber pressure--important to protecting blinding if they were to participate in blinded hyperbaric oxygen (HBO2) trials.
METHODS: Experienced divers and chamber attendants were randomized by appointment group to one of four pressure changes. These pressure changes caused volume changes corresponding to starting compression from sea level or altitude, with final pressures of 1.5 atm abs (breathing 100% oxygen) or 1.2 atm abs (breathing air). Following the pressure excursions, participants estimated their depth in feet of sea water (fsw) and breathing gas.
RESULTS: 42 volunteers participated: 10 females, 32 males, age 46 +/- 10 years (mean +/- 1 SD), dive experience 366 +/- 562 dives. Four were chamber attendants. When estimating the depth exposure, 19/42 (45%) selected I do not know. 3/23 (13%) were within 2 fsw of the actual depth (correlation between actual depth and estimate -0.0067) (p = 0.98). Two underestimated their depth. We found no indication of cluster randomization effect (p = 0.16). Participants could not discern breathing air or oxygen.
CONCLUSIONS: The results suggest experienced divers cannot discriminate chamber pressures of 1.2 and 1.5 atm abs, and could be included in hyperbaric clinical trials using this dosing without compromising masking integrity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908836

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  3 in total

1.  A single session of hyperbaric oxygen therapy demonstrates acute and long-lasting neuroplasticity effects in humans: a replicated, randomized controlled clinical trial.

Authors:  Anna M Wahl; Daniel Bidstrup; Isabel G Smidt-Nielsen; Mads U Werner; Ole Hyldegaard; Per Rotbøll-Nielsen
Journal:  J Pain Res       Date:  2019-07-31       Impact factor: 3.133

Review 2.  Looking for more than hot air: how experimental design can enhance clinical evidence for hyperbaric oxygen therapy.

Authors:  Adam T Biggs; Lanny F Littlejohn
Journal:  Med Gas Res       Date:  2022 Oct-Dec

Review 3.  Double-blind trials in hyperbaric medicine: A narrative review on past experiences and considerations in designing sham hyperbaric treatment.

Authors:  C A Lansdorp; Rob A van Hulst
Journal:  Clin Trials       Date:  2018-06-04       Impact factor: 2.486

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.